ACUTE MYELOID LEUKAEMIA
Clinical trials for ACUTE MYELOID LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKAEMIA trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new oral drug take on hard-to-treat leukaemia?
Disease control Not yet recruitingThis early-stage trial is testing an experimental drug called AMX-883, taken by mouth, for people with acute myeloid leukaemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or not responded to standard treatments. The study will first test AMX-883 alone, th…
Matched conditions: ACUTE MYELOID LEUKAEMIA
Phase: PHASE1 • Sponsor: Amphista Therapeutics Ltd • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New hope for AML patients: experimental drug IPN60340 enters key trial
Disease control Not yet recruitingThis study tests whether adding the experimental drug IPN60340 to standard medicines (azacitidine and venetoclax) helps more people with newly diagnosed acute myeloid leukemia (AML) achieve complete remission. About 450 adults who cannot have intensive chemotherapy will take part…
Matched conditions: ACUTE MYELOID LEUKAEMIA
Phase: PHASE2, PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC